Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Depigoid Grass Mix in patients with al-lergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.
Phase of Trial: Phase III
Latest Information Update: 29 Jul 2011
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis; Seasonal allergic rhinitis
- Focus Therapeutic Use
- 29 Jul 2011 New trial record